LAVIPHARM S.A. NA EO 1 (BXA0) — Financial Flexibility Index
LAVIPHARM S.A. NA EO 1 (BXA0) has a Financial Flexibility Index of 0.20x as of December 2024. Free cash flow of €14.28 Million (operating CF €4.64 Million minus capex €9.64 Million) represents 0% of total liabilities (€72.52 Million). Check LAVIPHARM S.A. NA EO 1 liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LAVIPHARM S.A. NA EO 1 Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for LAVIPHARM S.A. NA EO 1 across 4 annual periods. See LAVIPHARM S.A. NA EO 1 (BXA0) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year free cash flow to debt coverage for LAVIPHARM S.A. NA EO 1. For the full company profile including market capitalisation, see BXA0 market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.20x | €14.28 Million | €4.64 Million | €72.52 Million | ▲ +227.4% |
| 2023 | 0.06x | €4.33 Million | €284.00K | €72.02 Million | ▼ -88.6% |
| 2022 | 0.53x | €38.96 Million | €3.35 Million | €73.86 Million | ▲ +448.7% |
| 2021 | 0.10x | €6.03 Million | €4.11 Million | €62.68 Million | — |